Oxybutynin
Products Oxybutynin is commercially available in tablet form and as a transdermal patch (Ditropan, Kentera). It has been approved in many countries since 1988, and the transdermal patch has been available since 2007. Extemporaneous formulations are also produced; see Intravesical oxybutynin solution (for use in the urinary bladder). Other dosage forms have been released in … Oxybutynin